Pure Global
NCT06379516

Process Validation in Dermatology: Assessing Wound Creation Methods and Treatment Efficacy

Comprehensive Process Validation of Dermatological Wound Creation Techniques: A Study Evaluating Methodology Standardization for Assessment of Treatment Efficacy in Controlled Skin Damage
NovoBliss Research Pvt Ltd·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Validation of the Process of Wound Creation and Evaluation
Drug/Device/Intervention
Moisturising Cream (5%)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
NovoBliss Research Pvt Ltd
Location
Gandhinagar, India
Timeline & enrollment
Phase
N/A
Start date
Jan 17, 2024
End date
Feb 16, 2024
Enrollment
5 participants
Primary outcome

Trans Epidermal Water Loss (TEWL),Skin hydration,Skin surface topography

Summary

The primary objective of this study is to validate controlled methods of wound, including
 1%w/v SLS, 3%w/v SLS, and 24-24 times tape stripping, on the forearms of subjects.
 
 The study aims to standardize the procedures for creating wounds and systematically evaluate
 the effects of these methods on various skin parameters.

ICD-10 classifications
Open wounds involving other combinations of body regionsMultiple open wounds, unspecifiedOpen wounds involving multiple body regionsOpen wound of unspecified body regionOpen wounds involving multiple regions of lower limb(s)
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06379516
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06379516 through Pure Global AI's free database. This phase not specified trial is sponsored by NovoBliss Research Pvt Ltd and is currently Completed. The study focuses on Validation of the Process of Wound Creation and Evaluation. Target enrollment is 5 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.